← Back

$ Value

Shares

180,375

Price

Filed

Jul 21

Insider

Name

Kim Kyoung John

Title

Co-Chief Executive Officer

CIK

0001885540

Roles

Director Officer

Transaction Details

Transaction Date

2025-07-17

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

180,375

Footnotes

The shares of common stock were purchased by the Reporting Person in the Issuer's recently announced private placement with certain accredited and institutional investors, which closed on July 21, 2025. | The Reporting Person and the Issuer amended an existing option grant agreement pursuant to which the Reporting Person was granted options to purchase 180,375 shares of common stock of the Issuer (as adjusted for the Issuer's June 11, 2025 one-for-eight reverse stock split) in connection with the Reporting Person's employment service to the Company. The amendment increased the exercise price of such options to $10 per share of common stock. | The stock options vest based upon the daily volume weighted average price ("VWAP") of the Issuer's common stock, vesting as to 20% of the of the underlying shares of common stock upon the VWAP reaching $10 and then in incremental 20% installments until becoming fully vested upon a VWAP of $30. All vesting is subject to the approval by the Issuer's stockholder of a new stock option plan. | The stock options were issued by the Issuer in connection with the Reporting Person's employment service as Co-Chief Executive Officer of the Issuer on July 17, 2025. All vesting is subject to the approval by the Issuer's stockholders of a new stock option plan.

Filing Info

Accession No.

0001683168-25-005258

Form Type

4

Issuer CIK

0001829794

Kim Kyoung John's History

Date Ticker Type Value
2026-02-19 EMPD J $0
2026-02-19 EMPD J $0
2026-02-19 EMPD J $0
2025-07-21 VLCN A $225K
2025-07-17 VLCN A
2025-07-17 VLCN A
2025-05-30 VLCN A

Other Insiders at VLCN (90d)

Insider Bought Sold Last
ATG Capital Opportunities Fund LP $5.3M 2026-02-03
ATG Capital Management LP $5.3M 2026-02-03
Foster Jonathan P. 2026-02-18
Endo Greg
Chief Executive Officer
2026-02-18
Kim Kyoung John
Co-Chief Executive Officer
2026-02-19